Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hub Group A | HUBG | Mar 31, 2025 | 37.17 | +0.11 |
Hubbell | HUBB | Mar 31, 2025 | 330.91 | -0.33 |
HubSpot | HUBS | Mar 31, 2025 | 571.29 | -1.86 |
Hudbay Minerals | HBM | Mar 31, 2025 | 7.59 | -1.30 |
Hudson Global | HSON | Mar 31, 2025 | 10.67 | -0.47 |
Hudson Pacific Properties | HPP | Mar 31, 2025 | 2.95 | -0.67 |
Hudson Pacific Properties C Pref | HPP-C | Mar 31, 2025 | 13.16 | -2.59 |
Hudson Technologies | HDSN | Mar 31, 2025 | 6.17 | -0.16 |
HUHUTECH International Group | HUHU | Mar 31, 2025 | 4.16 | -6.52 |
Huize ADR | HUIZ | Mar 31, 2025 | 2.62 | 0.00 |
Humacyte | HUMA | Mar 31, 2025 | 1.71 | -13.01 |
Humana | HUM | Mar 31, 2025 | 264.60 | +0.01 |
Huntington Bancshares J Pref | HBANL | Mar 31, 2025 | 25.60 | -0.19 |
Huntington Bancshares Pref | HBANM | Mar 31, 2025 | 23.12 | +1.58 |
Huntington Bank | HBAN | Mar 31, 2025 | 15.01 | +1.49 |
Huntington Ingalls Industries | HII | Mar 31, 2025 | 204.04 | -0.62 |
Huntsman | HUN | Mar 31, 2025 | 15.79 | -0.19 |
Hurco Companies | HURC | Mar 31, 2025 | 15.51 | -0.70 |
Huron Consulting Group | HURN | Mar 31, 2025 | 143.45 | +0.81 |
Hut 8 | HUT | Mar 31, 2025 | 11.62 | -0.85 |
HUTCHMED (China) ADR | HCM | Mar 31, 2025 | 15.04 | -1.38 |
HUYA ADR A | HUYA | Mar 31, 2025 | 3.21 | -1.23 |
HWM International | HWH | Mar 31, 2025 | 1.24 | -8.82 |
Hyatt Hotels A | H | Mar 31, 2025 | 122.50 | +0.75 |
Hycroft Mining A | HYMC | Mar 31, 2025 | 3.24 | +5.88 |
Hydrofarm Holdings | HYFM | Mar 31, 2025 | 1.89 | -6.44 |
Hyliion A | HYLN | Mar 31, 2025 | 1.40 | -0.71 |
Hyperfine A | HYPR | Mar 31, 2025 | 0.72 | -0.51 |
Hyperscale Data | GPUS | Mar 31, 2025 | 2.23 | -8.61 |
Hyster-Yale A | HY | Mar 31, 2025 | 41.54 | -0.76 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.